Raymond James Reiterates Strong Buy on Encompass Health, Raises Price Target to $95
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst John Ransom reiterated a Strong Buy rating on Encompass Health (NYSE:EHC) and increased the price target from $85 to $95.
April 26, 2024 | 5:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Raymond James upgraded the price target for Encompass Health from $85 to $95 while maintaining a Strong Buy rating.
The upgrade in price target by a reputable analyst like John Ransom from Raymond James typically signals a strong bullish outlook on the stock, suggesting potential upside. This can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100